Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylation markers
FAM19A4
and
miR124
‐2
as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-10-01
DOI
10.1002/ijc.33320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study
- (2019) Kate T Simms et al. LANCET ONCOLOGY
- Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study
- (2019) Arno Floore et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Triaging HPV positive women with normal cytology or low grade dyskaryosis: evidence from 10 year follow‐up of the ARTISTIC trial cohort
- (2019) Clare Gilham et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans
- (2019) P.J. Maver et al. CLINICAL MICROBIOLOGY AND INFECTION
- Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis
- (2019) Stèfanie Dick et al. GYNECOLOGIC ONCOLOGY
- FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study
- (2019) Frederique J. Vink et al. INTERNATIONAL JOURNAL OF CANCER
- The use of molecular markers for cervical screening of women living with HIV in South Africa
- (2019) Wieke W. Kremer et al. AIDS
- Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
- (2019) Clare A. Aitken et al. BMC Medicine
- Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up
- (2018) Lise M.A. De Strooper et al. INTERNATIONAL JOURNAL OF CANCER
- Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer
- (2018) Wina Verlaat et al. Epigenetics
- The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium
- (2018) Jesper Bonde et al. JOURNAL OF CLINICAL VIROLOGY
- Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention
- (2016) Attila T. Lorincz ACTA CYTOLOGICA
- FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
- (2016) Roosmarijn Luttmer et al. BRITISH JOURNAL OF CANCER
- Validation of the FAM19A4 / mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
- (2016) Lise M.A. De Strooper et al. GYNECOLOGIC ONCOLOGY
- Use of HPV testing for cervical screening in vaccinated women-Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study
- (2016) Ramya Bhatia et al. INTERNATIONAL JOURNAL OF CANCER
- The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
- (2016) Ditte Ejegod et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway—PaVDaG study)
- (2016) Grazyna Stanczuk et al. BMJ Open
- Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
- (2015) M. Arbyn et al. CLINICAL MICROBIOLOGY AND INFECTION
- Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
- (2015) Christine Bergeron et al. JNCI-Journal of the National Cancer Institute
- Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
- (2015) Christine Bergeron et al. JNCI-Journal of the National Cancer Institute
- ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
- (2014) HC Kitchener et al. HEALTH TECHNOLOGY ASSESSMENT
- CADM1,MALandmiR124-2methylation analysis in cervical scrapes to detect cervical and endometrial cancer
- (2014) Lise M A De Strooper et al. JOURNAL OF CLINICAL PATHOLOGY
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
- (2012) D C Rijkaart et al. BRITISH JOURNAL OF CANCER
- Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer
- (2012) M. A. Clarke et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening
- (2011) M. Poljak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis
- (2009) Renée M Overmeer et al. JOURNAL OF PATHOLOGY
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
- (2009) Maarit Leinonen et al. JNCI-Journal of the National Cancer Institute
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started